169 related articles for article (PubMed ID: 30449229)
21. Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report.
Kubo C; Nagata S; Fukuda T; Kano R; Tanaka T; Nakanishi K; Ohsawa M; Nakatsuka SI
Diagn Pathol; 2018 Jun; 13(1):43. PubMed ID: 29960592
[TBL] [Abstract][Full Text] [Related]
22. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
Tang L; Zheng M; Xiong Y; Ding H; Liu FY
Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
[TBL] [Abstract][Full Text] [Related]
23. [Diagnostic challenges on breast needle core biopsies. Case 7: Metastasis of ovarian cancer to the breast].
Michenet P
Ann Pathol; 2017 Oct; 37(5):402-407. PubMed ID: 28939203
[No Abstract] [Full Text] [Related]
24. AgNORs count correlates better than grading with the effect of chemotherapy in serous ovarian cancer.
Gottwald L; Danilewicz M; Suzin J; Wójcik-Krowiranda K; Bieńkiewicz A
Pol J Pathol; 2003; 54(4):239-42. PubMed ID: 14998291
[TBL] [Abstract][Full Text] [Related]
25. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin.
Bagby C; Ronnett BM; Yemelyanova A; Maleki Z; Kuhn E; Vang R
Int J Gynecol Pathol; 2013 Sep; 32(5):433-43. PubMed ID: 23896706
[TBL] [Abstract][Full Text] [Related]
26. Ovarian cancer metastatic to the breast.
Laifer S; Buscema J; Parmley TH; Rosenshein NB
Gynecol Oncol; 1986 May; 24(1):97-102. PubMed ID: 3699579
[TBL] [Abstract][Full Text] [Related]
27. Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy.
Ayres C; Ratnayake G; McNally O; Quinn M
Int J Gynecol Cancer; 2017 May; 27(4):703-707. PubMed ID: 28399030
[TBL] [Abstract][Full Text] [Related]
28. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
29. Axillary lymph node metastasis from serous ovarian cancer: a case report and review of the literature.
Aydin C; Unalp HR; Baloğlu A; Inci AG; Yiğit S; Yavuzcan A
Arch Gynecol Obstet; 2009 Feb; 279(2):203-7. PubMed ID: 18470522
[TBL] [Abstract][Full Text] [Related]
30. Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.
Yalcin I; Meydanli MM; Turan AT; Taskin S; Sari ME; Gungor T; Akbayir O; Ayhan A
Int J Clin Oncol; 2018 Apr; 23(2):329-337. PubMed ID: 29143144
[TBL] [Abstract][Full Text] [Related]
31. Metastatic serous carcinoma presenting as inflammatory carcinoma over the breast-Report of two cases and literature review.
Panse G; Bossuyt V; Ko CJ
J Cutan Pathol; 2018 Mar; 45(3):234-239. PubMed ID: 29194708
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of Incidental Fallopian Tube High-Grade Serous Carcinoma and Serous Tubal Intraepithelial Carcinoma in Women at Low Risk of Hereditary Breast and Ovarian Cancer.
Chay WY; McCluggage WG; Lee CH; Köbel M; Irving J; Millar J; Gilks CB; Tinker AV
Int J Gynecol Cancer; 2016 Mar; 26(3):431-6. PubMed ID: 26807643
[TBL] [Abstract][Full Text] [Related]
33. A rare case of recurrent ovarian cancer presenting as a round ligament metastasis.
Togami S; Kato T; Oi T; Ishikawa M; Onda T; Ikeda S; Kasamatsu T
World J Surg Oncol; 2011 Nov; 9():144. PubMed ID: 22059859
[TBL] [Abstract][Full Text] [Related]
34. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer.
Méndez LE; Mueller A; Salom E; González-Quintero VH
Obstet Gynecol; 2003 Nov; 102(5 Pt 2):1200-2. PubMed ID: 14607056
[TBL] [Abstract][Full Text] [Related]
35. Intramedullary spinal cord metastasis from ovarian carcinoma.
Cormio G; Di Vagno G; Di Fazio F; Loverro G; Selvaggi L
Gynecol Oncol; 2001 Jun; 81(3):506-8. PubMed ID: 11371147
[TBL] [Abstract][Full Text] [Related]
36. Low-grade ovarian cancer in an adolescent patient.
Parker LP; Ramirez PT; Broaddus R; Sightler S; Wolf JK
Gynecol Oncol; 2001 Jan; 80(1):104-6. PubMed ID: 11136580
[TBL] [Abstract][Full Text] [Related]
37. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
38. A diagnostic dilemma following risk-reducing surgery for BRCA1 mutation - a case report of primary papillary serous carcinoma presenting as sigmoid cancer.
Chand M; Moore PJ; Clarke AD; Nash GF; Hickisk T
World J Surg Oncol; 2007 Sep; 5():102. PubMed ID: 17850658
[TBL] [Abstract][Full Text] [Related]
39. Palliative radiotherapy for the skin metastasis of ovarian cancer: a case report and review of the literature.
Demirci S; Yavas F; Ozsaran Z; Ozsaran A; Dikmen Y; Zekioglu O; Karabulut B; Aras AB
Med Oncol; 2010 Sep; 27(3):628-31. PubMed ID: 19536657
[TBL] [Abstract][Full Text] [Related]
40. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
